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Abstract
Introduction:  The  burden  of  Streptococcus  pneumoniae  infections  is  highest  in  chil-
dren.  Estimates  in  adult  population  are  uncommon.  We  determined  the  burden  of
disease  associated  with  pneumococcus  in  adults  in  Colombia  in  year  2008.
Methodology:  Using  different  data  sources  (ofﬁcial  mortality  records,  medical
databases,  published  literature  and  local  epidemiological  data)  we  estimated  preva-
lence,  incidence,  mortality  and  disability  due  to  bacterial  pneumonia,  bacterial
meningitis  and  bacteremia  of  any  cause  for  year  2008,  and  the  fraction  of  these
that  can  be  attributed  to  S.  pneumoniae.
Results:  A  total  of  63,463  DALYs  are  lost  due  to  S.  pneumoniae  in  Colombians  age  15
or  over.  Most  of  this  burden  (51,848  DALYs,  81.7%)  is  due  to  pneumonia,  followed  by
meningitis  (9241  DALYs,  14.6%).  The  three  conditions,  overall,  represent  2.03  DALYs
per  1000  Colombians  in  that  age  range.
Conclusions:  Despite  the  lower  incidence  of  pneumococcal  disease  in  adults,  as
compared  with  children,  its  burden  is  still  signiﬁcant,  comparable  to  that  of
schizophrenia  or  epilepsy.  This  study  may  provide  a  benchmark  for  future  preventive
interventions.
©  2012  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
Ltd.  All  rights  reserved.
tIntroductionBurden  of  disease  studies  provide  useful  informa-
tion  on  the  priority  setting  in  public  health.  This
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http://dx.doi.org/10.1016/j.jiph.2012.04.003ype  of  study  was  pioneered  in  the  United  States
s an  initiative  of  the  World  Health  Organization
WHO). The  aim  was  to  prioritize  interventions
or countries  at  different  stages  of  development
1,2] and  to  consider  this  information  in  a  cost-
ffectiveness  context,  establishing  the  possible
mpact of  individual  interventions  [3,4].
DALYs (Disability-Adjusted  Life  Years)  were
eveloped as  a  single-utility  measure  to  deter-
ine the  burden  attributable  to  a speciﬁc  disease
 Sciences. Published by Elsevier Ltd. All rights reserved.
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Table  1  The  ten  most  important  medical  conditions  in  Colombia,  ranked  according  to  their  burden  in  DALYs  per
1000  Colombians  of  all  ages  (adapted  from  [5]).
Ranking  Condition  DALYs  YLD  YLL
1 Hypertension  53.521  52.627  0.895
2 Major  depression 47.304  47.302  0.001
3 Dental  caries 26.277  26.277  —
4  Birth  trauma  15.506  12.219  3.287
5  Violence  14.795  0.082  14.713
6  Low  birth-weight  11.218  11.055  0.162
7  COPD  9.812  8.469  1.344
8  Asthma  9.223  9.041  0.182
9  Glaucoma  7.001  7.001  —
10 Ischemic  heart  disease 6.008  0.350  5.659
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DYLD, years lost to disability; YLL, years of life lost; COPD, chro
r  group  of  diseases.  DALYs  combine  premature
ortality (years  of  life  lost  because  of  premature
ortality, or  YLLs)  with  morbidity  (years  of  healthy
ife lost  as  a  result  of  disability,  or  YLDs),  which  are
eighted by  the  severity  of  the  disability.  In  con-
rast with  the  QALY  (Quality-Adjusted  Life  Year),
hich provides  a  measure  of  health  gains,  the  DALY
hows health  losses,  reﬂecting  the  severity  of  a
isease on  a  scale  from  0  (equivalent  to  perfect
ealth) to  1 (death)  [1].
In Table  1,  we  present  the  ten  most  important
edical conditions  ranked  according  to  their  bur-
en of  disease  per  1000  Colombians  of  all  ages  in
005 [5].
Streptococcus  pneumoniae  (or  pneumococcus)  is
he main  cause  of  community-acquired  pneumonia
nd meningitis  at  all  ages.  Although  most  infections
ccur in  children  up  to  2 years  of  age  and  in  older
dults over  65  [6],  the  incidence  of  pneumococ-
al infection  is  still  signiﬁcant  in  previously  healthy
ounger  adults  [7].  Most  burden  of  disease  studies
f S.  pneumoniae  have  concentrated  on  either  chil-
ren [8,9]  or  older  adults  [10,11].  If  little  is  known
bout  the  disease  in  these  age  groups  in  developed
ountries, even  less  is  known  of  the  burden  in  adult
opulations  in  developing  countries  [12].  This  paper
nalyzes  the  burden  of  disease,  estimated  in  DALYs,
n these  somehow-neglected  younger  and  middle-
ged adults  in  Colombia.
ethods
e  estimated  the  incidence  of  pneumococcal  dis-
ase in  the  Colombian  population  age  15  or  older  for
008 using  different  sources.  Colombia  has  a  nation-
ide mandatory  registry  of  health  interventions
alled RIPS  (Spanish  for  Individual  Registry  of  Health
ervices),  which  was  created  in  2000.  RIPS  currently
T
w
p
(bstructive pulmonary disease.
ontains  data  on  age,  gender,  and  medical  diagnosis
codiﬁed  according  to  the  International  Statistical
lassiﬁcation of  Diseases  and  Related  Health  Prob-
ems version  10  [ICD-10])  for  patients  treated  by  the
olombian  health  system  in  each  calendar  year  by
oth public  and  private  providers.  The  ICD-10  codes
sed were  as  follows:  G00,  G01,  G03.9,  G04.2,
04.8, and  G04.9  for  meningitis;  A40  and  A41  for
acteremia;  and  J13-J16  and  J18  for  pneumonia.
n adjustment  was  performed  to  correct  for  under-
eporting  (a  statistical  analysis  by  Rodriguez-Garcia
13] estimated  that  RIPS  reported  35%  of  actual
ases). One  assumption  was  that  underreporting
ffects all  age  groups  equally.  Because  underre-
orting is higher  in  local,  rural  and  small  hospitals,
e assumed  that  pneumonia  data  would  be  more
ncertain  than  bacteremia  and  meningitis,  which
re generally  treated  in  larger,  more  complex  hos-
itals. Therefore,  we  also  performed  estimations  in
 second  scenario  assuming  that  the  incidence  and
revalence  data  for  pneumonia  in  Colombia  were
imilar to  the  incidence  and  prevalence  estimated
y Murray  and  Lopez  for  the  whole  of  Latin  America,
ased  on  Argentinian,  Brazilian  and  Chilean  infor-
ation sources  [2].
To  estimate  mortality,  we  searched  the  2008
atabase of  the  Colombian  National  Statistics
gency (DANE),  which  contains  general  population
ortality rates  and  speciﬁc  mortality  rates  for  bac-
eremia, meningitis,  and  pneumonia.  The  cause  of
eath is  determined  by  the  physician,  who  signs
he death  certiﬁcate,  and  is  classiﬁed  using  ICD-
0 codes.  For  convenience,  the  information  was
rouped  into  the  same  ﬁve  age  intervals  used  by
ANE: 15—44,  45—64,  65—74,  75—80,  and  >80  years.
he 2008  Colombian  population  for  each  age  group
as estimated  by  interpolating  data  from  the  2005
opulation  census  and  ofﬁcial  projections  for  2010
see Table  2).
356  D.  Rosselli,  J.-D.  Rueda
Table  2  Crude  Colombian  mortality  for  each  of  the  conditions  of  interest.
Age  Population  Total  deaths  Bacteremia  Meningitis  Pneumonia
15—44  20,756,067  34,770  135  161  648
45—64  7,689,285  37,289  258  137  971
65—74  1,781,219  67,381  354  63  3124
75—80  527,843  14,051  178  33  846
80+ 557,334 27,235  351  58  899
Total 31,311,748 180,726 1276  452  6488
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In  the  DANE  ﬁgures,  mortality  rates  are  reported
for persons  older  than  65  years  as  a  single  age
group. We  assumed  a  constant  proportion  of  deaths
attributable  to  pneumonia,  meningitis  or  bac-
teremia  for  any  cause.  Mortality  rates  were  also
adjusted  for  underreporting,  which  has  been  esti-
mated at  9%  by  two  independent  studies  [5,14].  This
rate was  applied  equally  to  all  age  groups  (assump-
tion  based  on  Ruiz  and  Hincapie  [14],  who  found  the
highest underreporting  for  newborns  and  infants).
DALYs attributable  to  disability  were  calculated
using the  standard  method  proposed  by  Murray  and
Lopez [1].  The  ﬁnal  value  results  from  the  average
weight  of  disability  from  the  sequelae  associated
with each  disease.  Because  disability  weights  spe-
ciﬁc for  Colombia  have  not  been  estimated,  we
assumed  weights  reported  by  a  Chilean  burden  of
disease study  [15],  which  were  0.521  and  0.920  for
the acute  phases  of  pneumonia  and  bacteremia,
respectively,  and  0.541  for  the  sequelae  of  menin-
gitis (which,  in  contrast  to  the  other  two  diseases,
was applied  to  the  entire  life  expectancy).  This
last weight  is  compatible  with  a  meta-analysis  by
Jit [16],  who  reviewed  63  studies  that  involved
3408 patients  who  survived  pneumococcal  menin-
gitis.  In  his  paper,  the  following  sequelae  were
identiﬁed:  hearing  loss  (20.9%),  seizures  (6.5%),
hydrocephalus  (6.8%),  spasticity/paresis  (8.7%),
cranial  nerve  palsies  (12.2%),  and  visual  impairment
(2.4%).  Based  on  our  panel  of  experts,  we  assumed
that survivors  of  pneumonia  and  bacteremia  had  no
sequelae, so  YLDs  were  estimated  during  the  acute
phase  of  the  disease  only  (which  was  assumed  to
last for  two  weeks  for  both  pneumonia  and  bac-
teremia).
To estimate  the  DALYs  attributable  to  prema-
ture death,  we  used,  as  is  the  current  practice
[1,2], Japanese  life-expectancy  tables  adjusted  by
age and  gender.  DALYs  are  conventionally  estimated
using the  following  formulas:DALYs  =  YLLs  +  YLDs,
3
n
a
[here  YLLs  are  years  of  life  lost  and  YLDs  are
ears lost  to  disability.  The  YLL  and  YLD  formu-
as incorporate  three  key  assumptions:  r  is  the
nnual  discount  rate,  and  K and  ˇ  are  parameters
or weighting  the  function  of  age.  To  reﬂect  the
ase case  recommended  and  used  by  Murray  and
opez [1,2],  our  calculation  assumes  r =  0.03,  K =  1,
nd ˇ  =  0.004,  which  means  that  we  use  an  annual
iscount  rate  of  3%  and  differential  weight  for
ge.
Because RIPS  provides  information  on  bacterial
neumonia, bacterial  meningitis  and  bacteremia  of
ny cause,  we  estimated  the  burden  of  disease
ttributable to  S.  pneumoniae  for  each  condi-
ion by  calculating  the  proportion  of  cases  caused
y this  microorganism  according  to  published
egional epidemiology  records  (search  strategy:
‘(Pneumonia, Bacterial/epidemiology’’  [Mesh]  OR
‘Meningitis, Bacterial/epidemiology’’  [Mesh]  OR
‘Bacteremia/epidemiology’’  [Mesh])  AND  (‘‘Latin
merica’’  [Mesh])  in  PubMed,  with  equivalent
earches for  Embase  and  SciELO).  These  proportions
ere broadly  assumed  to  be  80%  of  all  community-
cquired pneumonia  [17—21],  50%  of  all  bacterial
eningitis cases  [22,23]  and  20%  of  all  bacteremias
24] in  adults.
esults
ccording  to  ofﬁcial  records,  in  2008,  7476  deaths
ere attributable  to  any  of  the  three  diseases
f interest  (pneumonia,  bacteremia  and  menin-
itis of  presumed  or  conﬁrmed  bacterial  origin).
fter adjusting  for  9%  underreporting,  these  ﬁgures
ccounted  for  4.5%  of  all  deaths  in  that  period  (see
able 2  for  adjusted  mortality).
During  this  same  period,  55,758  episodes  of  bac-
erial pneumonia,  350  cases  of  bacteremia,  and
36 cases  of  bacterial  meningitis  were  reported
ationwide in  RIPS.  These  data  were  adjusted  by
ssuming  that  they  represented  35%  of  all  cases
13].  Table  3 shows  the  total  DALYs  attributable  to
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Table  3  DALYs  estimated  for  pneumonia  due  to  S.  pneumoniae  in  two  possible  scenarios:  Scenario  1  is  adjusting
RIPS  data  for  underreporting,  and  Scenario  2  is  assuming  incidence  data  from  Murray  and  Lopez  for  all  of  Latin
America  [2].  Totals  are  presented  both  in  absolute  terms  and  as  a  proportion  per  1000  Colombians  age  15  or  over.
Age YLL  Scenario  1  Scenario  2
YLD DALYs YLD DALYs
15—44  15267.9  1248.8  16516.7  1827.1  17095.0
45—64  11306.7  615.9  11922.6  933.5  12240.2
65—74  18085.6  300.3  18385.9  470.7  18556.3
75—79  2939.7  119.5  3059.2  194.9  3134.6
80+  1695.6  267.9  1963.5  465.6  2161.2
Total 49295.5  2552.3  51847.8  3891.7  53187.2
Per  1000  1.5743  0.0815  1.6558  0.1242  1.6986
Table  4  DALYs  estimated  for  bacterial  meningitis  and  bacteremia  of  any  cause.  Totals  are  presented  both  in
absolute  terms  and  as  a  proportion  per  1000  Colombians  age  15  or  over.
Age Bacteremia Meningitis
YLL  YLD  DALYs  YLL  YLD  DALYs
15—44  784.4  5.8  790.2 2351.3  4112.3  6463.6
45—64  752.6  2.4  755.0 993.5  1203.6  2197.1
65—74  507.3  0.5  507.8 219.2  154.9  374.2
75—79  154.0  0.1  154.2 70.1  30.0  100.0
80+  166.3  0.3  166.6 67.8  39.1  106.9
Total  2364.7  9.1  2373.8 3702.0  5539.8  9241.8
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neumococcal  pneumonia  in  Colombia  in  the  two
cenarios  (adjusting  for  underreporting  and  extrap-
lating data  from  Murray  and  Lopez  [2]).  In  both
ases,  most  of  the  burden  for  pneumonia  is  due  to
remature  mortality.
In  Table  4,  we  present  our  estimations  of  the  bur-
en of  bacteremia  and  meningitis  attributable  to  S.
neumoniae. As  shown,  most  of  the  burden  in  bac-
eremia  is  due  to  premature  mortality,  whereas  the
mpact of  meningitis  is  due  to  its  associated  disabil-
ty. In  Tables  3  and  4,  we  present  the  results  both
s the  absolute  number  of  DALYs  and  as  a  ratio  per
000 inhabitants.
iscussion
his  study  has  several  limitations,  which  are
ainly due  to  the  quality  of  local  informa-
ion. Colombia  is  attempting  to  improve  its
ealth-related  information  systems,  and  its  mor-
ality records  are  considered  quite  reliable.  The
egistration  of  health  interventions,  however,
till underreports  morbidity,  and  the  adjustment
e performed  could  be  open  to  discussion,
M
w
c
P 0.1182  0.1769  0.2951
articularly  when  applied  equally  to  all  age  groups.
 recent  paper  by  Castaneda-Orjuela  et  al.,  who
sed different  sources  to  estimate  the  incidence  of
nvasive pneumococcal  disease  in  the  capital  city
f Bogota,  showed  ﬁgures  similar  to  ours  [25].  The
raction of  infections  that  could  be  attributable  to
. pneumoniae  is  another  limitation  of  our  analysis;
rude ﬁgures  for  bacterial  pneumonia,  meningitis
nd bacteremia  are,  no  doubt,  closer  to  reality.
With these  limitations  and  based  on  our  data,
he burden  of  pneumococcal  disease  in  adults  in
olombia  could  be  expressed  as  2.03  DALYs  per  1000
nhabitants  when  we  combine  pneumonia,  meningi-
is and  bacteremia  attributable  to  S.  pneumoniae.
his result  places  this  group  of  diseases  in  a  posi-
ion close  to  those  held  by  schizophrenia  (with  2.65
ALYs per  1000)  and  epilepsy  (2.07  DALYs  per  1000)
5].
In this  paper,  we  provide  an  estimate  of pneu-
ococcal disease  in  a  population  that  has  not  been
eriously considered,  even  in  developed  countries.
ost of  the  burden  is  represented  by  pneumonia,
hich has  a  high  incidence  and  is  an  important
ause of  death  throughout  the  entire  lifespan.
neumococcal meningitis  causes  severe  disability,
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despite  its  relatively  low  incidence.  The  total  num-
ber of  DALYs,  with  more  than  sixty  thousand  lost  per
year, and  the  relative  impact  per  1000  Colombian
adults can  be  considered  clinically  signiﬁcant  and
can provide  a  benchmark  to  estimate  and  evaluate
future  preventive  interventions.
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